Background During the ongoing COVID-19 pandemic, immunocompromised patients are at
a higher risk of severe infection, since the immune system has an important role in defeating …

The novel coronavirus, formerly called SARS-CoV-2 (severe acute respiratory syndrome
coronavirus 2), is a health threating disease that has so far spread from China to all around …

In the Wuhan province of China, almost two years ago, in December 2019, the novel
Coronavirus 2019 has caused a severe involvement of the lower respiratory tract leading to …

Introduction: While waiting for the development of specific antiviral therapies and vaccines to
effectively neutralize the SARS-CoV2, a relevant therapeutic strategy is to counteract the …

Background Hydroxychloroquine is not efficacious as post-exposure prophylaxis against
coronavirus disease 2019 (COVID-19). It is not known whether as pre-exposure prophylaxis …

COVID-19 has now spread globally, and 10–20% of the cases are thought to proceed to a
severe condition. However, information on COVID-19 in immunodeficient patients remains …

The global spread of coronavirus disease-19 (COVID-19) caused by severe acute
respiratory syndrome coronavirus-2, which originated from Wuhan, China, is likely to have …

Background The therapeutic profile of the patients with rheumatoid arthritis (RA) commonly
consists of immunosuppressive and anti-inflammatory compounds. Here in this research, we …

Objectives The aim of this study is to evaluate risk factors for severe coronavirus disease
2019 (COVID-19) in patients with immune-mediated rheumatic diseases, stratified by …

Objectives To explore the clinical course and its dynamic features of immune status in
COVID-19 patients and find predictors correlated with severity and prognosis of COVID-19 …